JP2011515672A - 腎尿細管の損傷および疾患の診断のための方法およびマーカー - Google Patents

腎尿細管の損傷および疾患の診断のための方法およびマーカー Download PDF

Info

Publication number
JP2011515672A
JP2011515672A JP2011500224A JP2011500224A JP2011515672A JP 2011515672 A JP2011515672 A JP 2011515672A JP 2011500224 A JP2011500224 A JP 2011500224A JP 2011500224 A JP2011500224 A JP 2011500224A JP 2011515672 A JP2011515672 A JP 2011515672A
Authority
JP
Japan
Prior art keywords
markers
sample
marker
polypeptide
renal tubular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011500224A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011515672A5 (enExample
Inventor
ミシャク、ハラルド
Original Assignee
モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー filed Critical モザイクス ダイアグノスティクス アンド セラピューティクス アーゲー
Publication of JP2011515672A publication Critical patent/JP2011515672A/ja
Publication of JP2011515672A5 publication Critical patent/JP2011515672A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2011500224A 2008-03-19 2009-03-19 腎尿細管の損傷および疾患の診断のための方法およびマーカー Pending JP2011515672A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP08153007 2008-03-19
EP08153007.3 2008-03-19
EP08167429.3 2008-10-23
EP08167429 2008-10-23
PCT/EP2009/053242 WO2009115570A2 (de) 2008-03-19 2009-03-19 Verfahren und marker zur diagnose von tubulären nierenschäden und -erkrankungen

Publications (2)

Publication Number Publication Date
JP2011515672A true JP2011515672A (ja) 2011-05-19
JP2011515672A5 JP2011515672A5 (enExample) 2012-05-17

Family

ID=40671165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011500224A Pending JP2011515672A (ja) 2008-03-19 2009-03-19 腎尿細管の損傷および疾患の診断のための方法およびマーカー

Country Status (4)

Country Link
US (1) US20120037507A9 (enExample)
EP (1) EP2255203A2 (enExample)
JP (1) JP2011515672A (enExample)
WO (1) WO2009115570A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060286602A1 (en) * 2004-05-10 2006-12-21 Harald Mischak Method and markers for the diagnosis of renal diseases
AU2008223791B2 (en) * 2007-03-07 2013-10-03 Mosaiques Diagnostics And Therapeutics Ag Method for the standardization of the concentration of analytes in a urine sample
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
AU2008309605A1 (en) * 2007-10-09 2009-04-16 Mosaiques Diagnostics And Therapeutics Ag Polypeptide marker for the diagnosis of prostate cancer
EP2051078A1 (de) * 2007-10-19 2009-04-22 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Diabetes Mellitus
EP2338054A1 (de) * 2008-09-17 2011-06-29 Mosaiques Diagnostics And Therapeutics AG Nierenzellkarzinom
CA2766228A1 (en) * 2009-07-02 2011-01-06 Mosaiques Diagnostics And Therapeutics Ag Process and markers for the diagnosis of acute renal failure
WO2011152339A1 (ja) * 2010-05-31 2011-12-08 Tanaka Noriaki 慢性腎臓病の病期を判定する方法又は装置若しくはその作動方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063090A1 (de) * 2005-11-30 2007-06-07 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung der ureterabgangsstenose
WO2007082586A1 (en) * 2006-01-20 2007-07-26 Mosaiques Diagnostics And Therapeutics Ag Method and markers for the diagnosis of renal diseases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6372249B1 (en) * 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
AU1674400A (en) * 1998-12-21 2000-07-12 Monash University Kidney disease detection and treatment
US6677114B1 (en) * 1999-04-20 2004-01-13 Target Discovery, Inc. Polypeptide fingerprinting methods and bioinformatics database system
DE10021737C2 (de) * 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
WO2002004950A2 (en) * 2000-07-12 2002-01-17 Werner Naser Direct assessment of analyte to reference molecule ratios
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
DE10304106A1 (de) * 2003-01-31 2004-08-26 Mosaiques Diagnostics And Therapeutics Ag Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
US7425700B2 (en) * 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
DE10341193A1 (de) * 2003-09-06 2005-03-31 Mosaiques Diagnostics And Therapeutics Ag Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen
US20050244973A1 (en) * 2004-04-29 2005-11-03 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer
US20060286602A1 (en) * 2004-05-10 2006-12-21 Harald Mischak Method and markers for the diagnosis of renal diseases
AU2005280528B2 (en) * 2004-07-30 2010-12-23 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
WO2006106129A2 (de) * 2005-04-07 2006-10-12 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnose von prostatakrebs
EP1757939A1 (de) * 2005-08-26 2007-02-28 mosaiques diagnostics and therapeutics AG Polypeptidmarker zur Diagnose von Blasenkrebs
AU2008223791B2 (en) * 2007-03-07 2013-10-03 Mosaiques Diagnostics And Therapeutics Ag Method for the standardization of the concentration of analytes in a urine sample
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
AU2008309605A1 (en) * 2007-10-09 2009-04-16 Mosaiques Diagnostics And Therapeutics Ag Polypeptide marker for the diagnosis of prostate cancer
EP2051078A1 (de) * 2007-10-19 2009-04-22 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Diabetes Mellitus
EP2338054A1 (de) * 2008-09-17 2011-06-29 Mosaiques Diagnostics And Therapeutics AG Nierenzellkarzinom
EP2394171A2 (de) * 2008-12-17 2011-12-14 mosaiques diagnostics and therapeutics AG Autosomal dominante polyzystische nierenerkrankung (adpkd)
CA2766228A1 (en) * 2009-07-02 2011-01-06 Mosaiques Diagnostics And Therapeutics Ag Process and markers for the diagnosis of acute renal failure
WO2011029954A2 (de) * 2009-09-14 2011-03-17 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063090A1 (de) * 2005-11-30 2007-06-07 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung der ureterabgangsstenose
WO2007082586A1 (en) * 2006-01-20 2007-07-26 Mosaiques Diagnostics And Therapeutics Ag Method and markers for the diagnosis of renal diseases

Also Published As

Publication number Publication date
US20120037507A9 (en) 2012-02-16
US20110036717A1 (en) 2011-02-17
EP2255203A2 (de) 2010-12-01
WO2009115570A2 (de) 2009-09-24
WO2009115570A3 (de) 2009-11-19

Similar Documents

Publication Publication Date Title
US20150024970A1 (en) Kidney cell carcinoma
JP2011515672A (ja) 腎尿細管の損傷および疾患の診断のための方法およびマーカー
US20140073057A1 (en) Process and markers for the diagnosis of kidney diseases
US20150346150A1 (en) Autosomal-dominant polycystic kidney disease (adpkd)
US20150122650A1 (en) Polypeptide markers for the diagnosis of bladder cancer
AU2006336091C1 (en) Method and markers for the diagnosis of renal diseases
US20120118737A1 (en) Method And Markers For Diagnosing Acute Renal Failure
JP2015507194A (ja) 心不全の診断および評価のためのポリペプチドマーカー
US20100248378A1 (en) Method and marker for diagnosing diabetes mellitus
CA2701571A1 (en) Polypeptide markers for the diagnosis of prostate cancer
US20060286602A1 (en) Method and markers for the diagnosis of renal diseases
US20100062537A1 (en) Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO)
JP2008537112A (ja) 前立腺がんの診断のためのポリペプチドマーカー
US20150126405A1 (en) Polypeptide markers for the early recognition of the rejection of transplanted kidneys
JP5147684B2 (ja) アルツハイマー病の診断のためのポリペプチドマーカー
KR20080091234A (ko) 신장 질환의 진단 방법 및 이를 위한 마커

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120319

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120319

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140220

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140819